Synaptics (NASDAQ: SYNA) officer sells 8,833 shares under 10b5-1 plan

Q: What insider transaction did Esther Song report for SYNAPTICS Inc (SYNA)?

Esther Song reported selling a total of 8,833 shares of Synaptics common stock. The trades were open-market sales executed on May 28, 2026 , broken into several transactions at different prices throughout the day.

Q: At what prices did Esther Song sell SYNA shares in this Form 4 filing?

The filing lists weighted-average prices from about $137.32 to $143.38 per share. Footnotes explain the shares were sold in multiple trades within narrow price ranges, and detailed trade data is available on request.

Q: How many separate sales did Esther Song make of SYNA stock on May 28, 2026?

The Form 4 shows six separate open-market sales of Synaptics common stock. Individual transactions ranged from 357 shares to 2,714 shares, together adding up to 8,833 shares sold on that date.

Q: Was Esther Song’s SYNA stock sale made under a Rule 10b5-1 trading plan?

Yes. A footnote states the shares were sold pursuant to a Rule 10b5-1 Trading Plan dated February 26, 2026 . Such plans are pre-arranged programs that schedule trades in advance to help manage insider trading risk.

Q: What type of security did Esther Song sell in this SYNA Form 4?

All reported transactions involve Synaptics common stock as non-derivative securities. There are no derivative exercises or option-related trades disclosed, and the derivative section of the filing contains no remaining derivative positions.

Q: How many SYNA shares did Esther Song sell in total according to the transaction summary?

The transaction summary shows 8,833 shares sold and no shares purchased . It characterizes the activity as a net-sell position for the day, with six open-market sale transactions and no derivative exercises or gifts reported.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Synaptics Inc. officer Esther Song reported multiple open-market sales of company common stock. On May 28, 2026, she sold a total of 8,833 shares at prices generally between about $137 and $143 per share under a pre-arranged Rule 10b5-1 Trading Plan dated February 26, 2026.

Insider Trade Summary 10b5-1

Net Seller: 8,833 shares ($1,246,959)

Net Sell 6 txns

Insider Song Esther

Role See Remarks

Sold 8,833 shs ($1.25M)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,200	$137.61	$165K
Sale	Common Stock	600	$139.10	$83K
Sale	Common Stock	1,361	$140.58	$191K
Sale	Common Stock	2,714	$141.75	$385K
Sale	Common Stock	2,601	$142.70	$371K
Sale	Common Stock	357	$143.32	$51K

Holdings After Transaction: Common Stock — 20,054 shares (Direct, null)

Footnotes (1)

The shares were sold pursuant to a 10b5-1 Trading Plan dated February 26, 2026. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $137.32 to $138.02, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $138.67 to $139.49, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $139.96 to $140.87, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $141.01 to $141.97, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $142.19 to $143.18, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $143.25 to $143.38, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Key Figures

Shares sold: 8,833 shares Transaction count: 6 sales Highest weighted-average price: $143.38/share +3 more

6 metrics

Shares sold 8,833 shares Total common shares sold on May 28, 2026

Transaction count 6 sales Number of open-market sale transactions on May 28, 2026

Highest weighted-average price $143.38/share Upper end of price range from one sale footnote

Lowest price range bound $137.32/share Lower end of disclosed sale price ranges

Largest single sale block 2,714 shares One non-derivative sale at $141.75 per share

Smallest single sale block 357 shares One non-derivative sale at $143.32 per share

Key Terms

Rule 10b5-1 Trading Plan, weighted average, open-market sale, non-derivative, +1 more

5 terms

Rule 10b5-1 Trading Plan regulatory

"The shares were sold pursuant to a 10b5-1 Trading Plan dated February 26, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average financial

"The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging..."

A weighted average is a way of calculating an overall number when some items matter more than others by giving each item a different level of importance, or weight. Investors use weighted averages to combine figures like prices, returns or earnings so the result reflects the size or significance of each part — like grading a class where a final exam counts more than a quiz, producing a score that better represents true performance.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

non-derivative financial

"transaction_type: "non-derivative""

net-sell financial

"netBuySellDirection: "net-sell""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

05/29/2026 - 04:16 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Song Esther

(Last)

(First)

(Middle)

1109 MCKAY DRIVE

(Street)

SAN JOSE

CALIFORNIA

95131

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SYNAPTICS Inc [ SYNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/28/2026		S		1,200⁽¹⁾	D	$137.61⁽²⁾	20,054	D
Common Stock	05/28/2026		S		600⁽¹⁾	D	$139.1⁽³⁾	19,454	D
Common Stock	05/28/2026		S		1,361⁽¹⁾	D	$140.58⁽⁴⁾	18,093	D
Common Stock	05/28/2026		S		2,714⁽¹⁾	D	$141.75⁽⁵⁾	15,379	D
Common Stock	05/28/2026		S		2,601⁽¹⁾	D	$142.7⁽⁶⁾	12,778	D
Common Stock	05/28/2026		S		357⁽¹⁾	D	$143.32⁽⁷⁾	12,421	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The shares were sold pursuant to a 10b5-1 Trading Plan dated February 26, 2026.

2. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $137.32 to $138.02, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $138.67 to $139.49, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $139.96 to $140.87, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

5. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $141.01 to $141.97, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

6. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $142.19 to $143.18, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

7. The reported price is a weighted average. These shares were sold in multiple transactions at prices ranging from $143.25 to $143.38, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Remarks:

The reporting person is Vice President and Corporate Controller.

	/s/ Pamela Fields, as attorney-in-fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Esther Song report for SYNAPTICS Inc (SYNA)?

Esther Song reported selling a total of 8,833 shares of Synaptics common stock. The trades were open-market sales executed on May 28, 2026, broken into several transactions at different prices throughout the day.

At what prices did Esther Song sell SYNA shares in this Form 4 filing?

The filing lists weighted-average prices from about $137.32 to $143.38 per share. Footnotes explain the shares were sold in multiple trades within narrow price ranges, and detailed trade data is available on request.

How many separate sales did Esther Song make of SYNA stock on May 28, 2026?

The Form 4 shows six separate open-market sales of Synaptics common stock. Individual transactions ranged from 357 shares to 2,714 shares, together adding up to 8,833 shares sold on that date.

Was Esther Song’s SYNA stock sale made under a Rule 10b5-1 trading plan?

Yes. A footnote states the shares were sold pursuant to a Rule 10b5-1 Trading Plan dated February 26, 2026. Such plans are pre-arranged programs that schedule trades in advance to help manage insider trading risk.

What type of security did Esther Song sell in this SYNA Form 4?

All reported transactions involve Synaptics common stock as non-derivative securities. There are no derivative exercises or option-related trades disclosed, and the derivative section of the filing contains no remaining derivative positions.

How many SYNA shares did Esther Song sell in total according to the transaction summary?

The transaction summary shows 8,833 shares sold and no shares purchased. It characterizes the activity as a net-sell position for the day, with six open-market sale transactions and no derivative exercises or gifts reported.